Tenaya (TNYA) CMO Tingley Whittemore Sells Shares

What Happened
Tingley Whittemore, Chief Medical Officer of Tenaya Therapeutics (TNYA), sold a total of 7,424 shares on August 17, 2026 in open-market/private sales (transaction code S) for aggregate proceeds of about $5,270. The sales were done to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-08-17 (filed same day).
• Individual lots reported: 1,637 shares (@ $0.71) = $1,162; 1,637 shares (@ $0.71) = $1,162; 1,871 shares (@ $0.71) = $1,328; 2,279 shares (@ $0.71) = $1,618.
• Weighted average sales price reported: $0.71; reported price range across sales: $0.6820–$0.7253 (per footnote F2). The filer will provide a breakdown of shares sold at each price on request.
• Reason: Shares sold to cover tax withholding on RSU vestings (footnotes F1, F4, F6, F8). This is routine tax-withholding activity (code F).
• Holdings after transaction: Filing notes multiple unvested RSU balances and other holdings — e.g., 108,544 RSUs (to be issued), 104,169 RSUs, 99,169 RSUs, 93,076 RSUs and 6,000 shares from the 2021 ESPP (per footnotes F3, F5, F7, F9). These reflect unvested awards that will issue upon vesting.
• Timeliness: Transaction and Form 4 were filed on the same date (timely).

Context
These sales are tax-withholding disposals tied to RSU vesting and are generally considered routine (not necessarily a signal of the insider’s view on the stock). Purchases or larger, discretionary open-market buys tend to be more informative about insider sentiment.